February 13, 2012 Ted W. Love, M.D. c/o Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco, CA 94080 Re: Transition and Retirement Agreement Dear Ted: As discussed, this letter sets forth the terms of the transition and retirement...Indemnity Agreement • May 4th, 2012 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
